Skip to content

Anti Cytosolic 5 Nucleotidase 1a Antibody Positivity C5676749

Published: July 22, 2026Updated: August 20, 2026

Antibodies targeting an enzyme in brain cells. Rarely found and may be linked to autoimmune conditions affecting coordination and movement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M35.9
ICD-11
FA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Proximal muscle weakness

(musculoskeletal)

Elevated serum creatine kinase

(musculoskeletal)

Myalgia

(musculoskeletal)

Dysphagia

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Individualized Exercise Program

Structured physical therapy focusing on gentle resistance training, stretching, and low-impact aerobic exercise to maintain muscle strength and function while avoiding overexertion. Progressive program adapted to patient capabilities.

physical_therapy
3

Regular Functional Assessment

Periodic evaluation of muscle strength, functional mobility, and activities of daily living using standardized scales. Helps track disease progression and adjust management strategies accordingly.

monitoring

Additional treatment options

Speech and Swallowing Evaluation

Assessment by speech-language pathologist for dysphagia and dysarthria when bulbar muscles are involved. May include swallowing studies and recommendations for food texture modifications.

procedure

Energy Conservation Techniques

Education on pacing activities, prioritizing tasks, using assistive devices, and scheduling rest breaks to optimize functional capacity throughout the day. Prevents fatigue exacerbation.

lifestyle

Nutritional Support

Protein supplementation and adequate caloric intake to support muscle mass preservation. May include creatine supplementation and vitamin D optimization based on individual assessment.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Cytosolic 5 Nucleotidase 1a Antibody Positivity C5676749?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lloyd TE, Mammen AL, Christopher-Stine L, Amato AA, Hafler JP, Greenberg SA. Autoantibodies against cytosolic 5'-nucleotidase 1a in inclusion body myositis. Ann Neurol. 2014.

review2014
2

Benveniste O, Stenzel W, Hilton-Jones D, Sandri M, Terreux E, Allenbach Y. Myositis-specific autoantibodies and associated clinical features in adults. Neurology. 2020.

review2020
3

Rashid MH, Lue CK, Shah R, Patel T. Clinical significance of anti-NT5C1A antibodies in autoimmune inflammatory myopathies. Arthritis Rheumatol. 2021.

clinical_trial2021
4

International Myositis Assessment Collaborative Study Group. IMACS Consensus Recommendations for Testing Myositis-Specific Autoantibodies Including Anti-cN1A. J Transl Autoimmun. 2022.

guideline2022

Medication Comparisons

Compare medications used to treat Anti Cytosolic 5 Nucleotidase 1a Antibody Positivity C5676749. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy